CARE Ratings
Stock Snapshot
Price Performance
Vista Outlook
View Technicals Analysis →Basis of our Recommendation
CARE Ratings is positioned for stable growth, bolstered by management's strategic initiatives and a favorable regulatory environment. The recent commercial launch of PaRRVA, a new regulatory initiative, is expected to enhance revenue streams and strengthen market positioning. Additionally, the company's focus on expanding its non-ratings and international businesses, alongside investments in AI-driven analytics, is likely to improve profitability and margins. Despite potential headwinds from geopolitical uncertainties and domestic economic challenges, the overall outlook remains positive. Vista's forecast anticipates consistent revenue growth and improving margins, supported by a fair valuation aligned with intrinsic value. The capital markets sector's growth trajectory, driven by regulatory reforms and increased foreign capital inflows, further underpins CARE Ratings' prospects. Over the next 12-24 months, key opportunities include leveraging the ESG ratings market and expanding international operations, while watchpoints include the impact of global economic conditions and corporate bond issuance trends on core ratings revenue
Why We Like This Stock
- The launch of PaRRVA is expected to generate new revenue and enhance market position
- Strategic investments in AI and analytics are transforming the business into a profitable, recurring revenue stream
- The capital markets sector is experiencing growth due to regulatory reforms and increased foreign capital inflows
Things To Watch Out For
- Geopolitical uncertainties and elevated oil prices may moderate India's GDP growth
- Potential decline in corporate bond issuances could impact core ratings revenue
- Long sales cycles and complex implementations in the non-ratings segment pose challenges
Key Parameters
Financial Snapshot
| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 332 | 402 | 473 | 496 | 571 |
| Profit Before Tax (Cr.) | 147 | 192 | 235 | 249 | 286 |
| PBT Margin | 44.3% | 47.8% | 4968.3% | 50.3% | 50.1% |
| Net Profit (Cr.) | 104 | 141 | 173 | 183 | 207 |
| Earnings Per Share | 33.9 | 45.8 | 56.6 | 59.9 | 68.8 |
Analyst Recommendations
No analyst recommendations available.
Company Overview
Show Company Profile
CARE Ratings Limited, a credit rating agency, provides various rating and related services in India and internationally. It offers rating services for bank loan, debt instrument, bonds, long and short term instruments, InvITs, resolution plan, and non-convertible debentures; CDs for banks, bonds, mutual funds, and hybrid instruments; bank debt and capital market instruments, such as commercial papers, corporate bonds and debentures, and structured credit; structured finance ratings; insurance ratings; recovery ratings; issuer ratings; ratings of REITs; public finance; and monitoring agency for equity capital. The company was formerly known as Credit Analysis and Research Limited and changed its name to CARE Ratings Limited in June 2017. CARE Ratings Limited was incorporated in 1993 and is headquartered in Mumbai, India.